Ningbo HEALTH Gene Technologies Co., Ltd.
PrivateLast Round
Corporate Funding
Jan 8, 2025
Total Funding Raised
$63.1M
Company Overview
Ningbo HEALTH Gene Technologies Co., Ltd. operates in Healthcare & Life Sciences and is based in Ningbo. Its latest recorded funding round was a Series C round in August 2022.
Ningbo HEALTH Gene Technologies Co., Ltd. is a medical laboratory technology company that develops, manufactures, and markets diagnostic solutions for clinical and forensic applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ningbo HEALTH Gene Technologies Co., Ltd. Comparables
Compare Ningbo HEALTH Gene Technologies Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Denogen (Beijing) Bio-Sci&Tech Co., Ltd. | 87% | |
| Beijing Microread Genetics Co., Ltd. | 86% | |
| Jiangsu Superbio Biomedical Co., Ltd. | 84% |
For institutional investors. Book with your work email.
Ningbo HEALTH Gene Technologies Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jan 8, 2025 | ||||
| Series C | Aug 8, 2022 | ||||
| Series A | Dec 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ningbo HEALTH Gene Technologies Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Series A, Series C |
| Boyuan Capital | Series A, Series C |
| 海愿资本 | Series B |
| GL Capital Group | Series A |
| Delian Capital | Series A |
| Blue Lake Capital | Series A |
| Qiming Venture Partners | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2025
Beckman Coulter led the corporate funding round.
- Aug 8, 2022
$29.4M round led by Shenzhen Capital Group.
For institutional investors. Book with your work email.
Ningbo HEALTH Gene Technologies Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ningbo HEALTH Gene Technologies Co., Ltd.'s valuation, stock price, and market status.
Is Ningbo HEALTH Gene Technologies Co., Ltd. a public or private company?
Ningbo HEALTH Gene Technologies Co., Ltd. is a private company.
What is the current stock price of Ningbo HEALTH Gene Technologies Co., Ltd.?
Ningbo HEALTH Gene Technologies Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Ningbo HEALTH Gene Technologies Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ningbo HEALTH Gene Technologies Co., Ltd. worth (valuation)?
Valuation information for Ningbo HEALTH Gene Technologies Co., Ltd. is not publicly available.
Can I buy Ningbo HEALTH Gene Technologies Co., Ltd. stock?
Ningbo HEALTH Gene Technologies Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ningbo HEALTH Gene Technologies Co., Ltd.'s last funding round?
Ningbo HEALTH Gene Technologies Co., Ltd.'s most recent funding round was Corporate Funding on January 8, 2025.
Who are the main investors in Ningbo HEALTH Gene Technologies Co., Ltd.?
Key investors in Ningbo HEALTH Gene Technologies Co., Ltd. include Qiming Venture Partners, Shenzhen Capital Group.
Will Ningbo HEALTH Gene Technologies Co., Ltd. IPO soon?
No public IPO plans have been announced for Ningbo HEALTH Gene Technologies Co., Ltd..
How can I track Ningbo HEALTH Gene Technologies Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Ningbo HEALTH Gene Technologies Co., Ltd.'s shares on secondary markets.